Overview: Eosinophils Sputum TestIntroduction: The Eosinophils Sputum Test detects eosinophils in sputum to diagnose asthma or allergies, causing wheezing. Aligned with 2023 GINA guidelines, it uses microscopy for high specificity, supporting allergy screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected eosinophilic lung conditions.
Other Names: Sputum Eosinophils Assay, Eosinophil Sputum Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Sputum eosinophil testing began in the 1980s with asthma research. Microscopy methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects eosinophils in sputum to diagnose asthma or allergies, guides treatment, and evaluates patients with wheezing.
Test Parameters: 1. Eosinophils Presence
Pretest Condition: No fasting required. Collect sputum. Report history of wheezing, asthma, or allergic symptoms.
Specimen: Sputum (sterile container, 5-10 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document wheezing, asthma, or history of allergies. Include current medications, especially corticosteroids.
Consent: Written consent required, detailing the tests purpose, asthma/allergy implications, and risks of sample collection.
Procedural Considerations: Uses stained microscopy to detect eosinophils in sputum. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for asthma or allergy diagnosis.
Factors Affecting Result Accuracy: Improper sputum collection or corticosteroid use can affect results. Low eosinophil counts reduce sensitivity.
Clinical Significance: Positive eosinophils confirm eosinophilic asthma or allergies, guiding corticosteroid therapy. Negative results may require bronchial challenge testing.
Specialist Consultation: Consult a pulmonologist or allergist for result interpretation and treatment planning.
Additional Supporting Tests: FeNO, spirometry, or allergy testing to confirm asthma/allergy diagnosis.
Test Limitations: Non-specific for certain lung conditions; clinical correlation is needed. Sample quality affects accuracy.
References: GINA Asthma Guidelines, 2023; Journal of Allergy and Clinical Immunology, Wenzel SE, 2022.
